Gut Microbiome clinical trials at UCSF
1 research study open to eligible people
The gut microbiome refers to the population of microbes in our digestive tract. UCSF is conducting trials to analyze health outcomes from fecal microbiota transplants. This research will contribute to a registry that tracks the effects of gut-related microbiome products in patients.
Showing trials for
Fecal Microbiota Transplant National Registry
open to all eligible people
A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness
San Francisco, California and other locations
Our lead scientists for Gut Microbiome research studies include Max Brondfield, MD.
Last updated: